Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer. Approximately 80% of patients initially diagnosed with locally advanced or metastatic disease survive only 4–11 months after diagnosis. Tremendous efforts have been made toward understanding the biology of PDAC. Results...
Guardado en:
Autores principales: | Hongjin Wu, Weiwei Tian, Xiang Tai, Xuanpeng Li, Ziwei Li, Jing Shui, Juehua Yu, Zhihua Wang, Xiaosong Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2ad0849a2ad476fb109ff4b4278cb8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
por: Dong-jin Wu, et al.
Publicado: (2018) -
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: Iranzu González-Borja, et al.
Publicado: (2021) -
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
por: Shin-Heng Chiou, et al.
Publicado: (2018) -
The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma
por: Ricki T. Krog, et al.
Publicado: (2021) -
Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a weighted gene co-expression network
por: Xinwang Yan, et al.
Publicado: (2021)